Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors

American Journal of Hematology - United States
doi 10.1002/ajh.24943

Related search